Osteonecrosis of the jaws associated with cancer chemotherapy
- PMID: 12966490
- DOI: 10.1016/s0278-2391(03)00328-8
Osteonecrosis of the jaws associated with cancer chemotherapy
Comment in
-
Bisphosphonates and bone necrosis.J Oral Maxillofac Surg. 2004 Mar;62(3):391-2. doi: 10.1016/j.joms.2003.11.003. J Oral Maxillofac Surg. 2004. PMID: 15015179 No abstract available.
Similar articles
-
Reversible life-threatening encephalopathy in the absence of hepatic failure following conventional doses of docetaxel.Clin Oncol (R Coll Radiol). 2003 May;15(3):160-1. doi: 10.1053/clon.2002.0191. Clin Oncol (R Coll Radiol). 2003. PMID: 12801056 No abstract available.
-
Meeting highlights 38th annual meeting of the American Society of Clinical Oncology. Advances in adjuvant chemotherapy for management of breast cancer: the emerging role of docetaxel.Gan To Kagaku Ryoho. 2002 Sep;29(9):1689-92. Gan To Kagaku Ryoho. 2002. PMID: 12355960 No abstract available.
-
[Docetaxel hydrate for treatment of advanced breast cancers].Nihon Rinsho. 2000 Apr;58 Suppl:254-8. Nihon Rinsho. 2000. PMID: 11026003 Review. Japanese. No abstract available.
-
Intestinal side-effects of docetaxel/vinorelbine combination.Lancet. 2000 Mar 25;355(9209):1098-9. doi: 10.1016/S0140-6736(05)72219-4. Lancet. 2000. PMID: 10744113 Clinical Trial. No abstract available.
-
Docetaxel. A review of its role in breast cancer treatment.Am J Clin Oncol. 1997 Aug;20(4):429-32. doi: 10.1097/00000421-199708000-00023. Am J Clin Oncol. 1997. PMID: 9256905 Review. No abstract available.
Cited by
-
Bisphosphonate - related osteonecrosis of the jaws: the point of view of the oral pathologist.Clin Cases Miner Bone Metab. 2007 Jan;4(1):53-7. Clin Cases Miner Bone Metab. 2007. PMID: 22460754 Free PMC article.
-
Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ.Front Endocrinol (Lausanne). 2023 Jan 20;14:1111627. doi: 10.3389/fendo.2023.1111627. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36742414 Free PMC article.
-
Higher incidence of Osteonecrosis of the Jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents.Cancer Invest. 2009 Feb;27(2):221-6. doi: 10.1080/07357900802208608. Cancer Invest. 2009. PMID: 19235596 Free PMC article. Clinical Trial.
-
Osteonecrosis of the jaw induced by clodronate, an alkylbiphosphonate: case report and literature review.Eur J Clin Pharmacol. 2010 Jun;66(6):547-54. doi: 10.1007/s00228-010-0822-5. Epub 2010 May 1. Eur J Clin Pharmacol. 2010. PMID: 20437036
-
Bisphosphonate-related osteonecrosis of the jaw in non-malignant bone disease.Rheumatol Int. 2013 Sep;33(9):2189-98. doi: 10.1007/s00296-013-2771-7. Epub 2013 May 8. Rheumatol Int. 2013. PMID: 23652790 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical